Ibrahim Hatipoglu

Ibrahim Hatipoglu is a Lecturer in the Department of Radiation Oncology at Washington University School of Medicine in St. Louis. He holds a BS in Biology from Istanbul University (2004), an MS in Biochemistry (2006) and PhD in Biology (2012) from Anadolu University, Turkey. His career includes postdoctoral research at Oklahoma Medical Research Foundation and previous faculty service at Yeditepe University in Turkey before joining Washington University as a visiting researcher and later as faculty.

His research focuses on radiation therapy's impact on immune cell functions within tumor microenvironments, with emphasis on dendritic cell biology, T-cell responses, and innate immunity mechanisms. Additional expertise spans virology (particularly Hepatitis B pathogenesis), cancer immunology, and biotechnological applications like monoclonal antibody development.

Analysis of Dr. Hatipoglu's 11 publications reveals three primary research phases: early work (2011-2013) on virology and cryobiology techniques; transitional cancer studies (2014-2017) investigating apoptosis mechanisms and dendritic cell biology; and recent research (2018-2019) focused on sex-biased immune responses and influenza immunity. His work consistently integrates immunology with oncology and virology.

Collaborative networks include researchers across Turkey and the United States, evidenced by multi-institutional publications. No specific awards, grants, or student advising relationships are detailed in available sources.